The kinase activity of PKR represses inflammasome activity

Howard C H Yim1,2, Die Wang1,2, Liang Yu3,2

  • 1Centre for Cancer Research, Hudson Institute of Medical Research, 27-31 Wright St, Clayton, Victoria 3168, Australia.

Cell Research
|January 23, 2016
PubMed

Insights

Protein kinase R (PKR) represses cryopyrin inflammasome activity by inhibiting protein translation, dampening innate immune inflammation. This finding contradicts previous reports and advises against PKR inhibition for treating inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • Protein kinase R (PKR) is a key mediator of the antiviral response, regulating protein translation and inflammatory signaling.
  • The precise role of PKR in inflammasome activation, particularly the cryopyrin inflammasome, remains incompletely understood.

Purpose of the Study:

  • To investigate the kinase-dependent and -independent functions of PKR.
  • To determine the role of PKR in regulating cryopyrin inflammasome activity.

Main Methods:

  • Generation of a knock-in mouse model expressing a kinase-inactive mutant of PKR.
  • Utilizing a PKR-deficient mouse model.
  • Assessing cryopyrin inflammasome activity in response to PKR modulation.

Main Results:

  • PKR represses, rather than activates, cryopyrin inflammasome activity, contrary to previous findings.
  • This repression is mediated by PKR's established role in inhibiting protein translation of inflammasome components.
  • PKR prevents inflammasome priming during innate immune signaling.

Conclusions:

  • PKR plays a crucial role in dampening inflammation during innate immune responses.
  • Therapeutic strategies aimed at inhibiting PKR to treat inflammation may be counterproductive.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K